Back to 
UBS Group AG
UBS Group AG
ONCO2 quarters
Position history for UBS Group AG's holdings in ONCONETIX INC
No. Ubs exited its ONCO (Onconetix) position in Q2 2026. Its Q1 2026 13F listed 1,580 shares worth $2,354. Ubs first reported ONCO in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$2,354
Total Shares Change
-1,580
Quarter-by-Quarter History
Other major holders of ONCO: GEODE CAPITAL MANAGEMENT, LLC, CITIGROUP INC